Epigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma

被引：7
|
作者：
Qi, Jing [1 ]
Shi, Lin-Ying [2 ]
Wu, Yin [2 ]
Shen, Xian-Juan [1 ]
Yuan, Jie [3 ]
Jin, Chun-Jing [3 ]
Cong, Hui [3 ]
Ju, Shao-Qing [3 ]
机构：
[1] Nantong Univ, Affiliated Hosp, Res Ctr Clin Med, Nantong, Jiangsu, Peoples R China
[2] Nantong Univ, Med Sch, Nantong, Jiangsu, Peoples R China
[3] Nantong Univ, Affiliated Hosp, Ctr Lab Med, 20 Xisi Load, Nantong 226001, Jiangsu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 13期
基金：
中国国家自然科学基金;
关键词：
Multiple myeloma; miR-335; methylation; insulin-like growth factor-1 receptor; migration; MESENCHYMAL STEM-CELLS; CANCER CELLS; EXPRESSION; INVASION; PROLIFERATION; PROGRESSION; PROGNOSIS; METHYLATION; SUPPRESSOR; BORTEZOMIB;
D O I：
10.1080/10428194.2019.1627534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multiple myeloma (MM) is a common hematological malignancy and remains incurable. MiRNA-335 is a classic tumor suppressor, yet its expression pattern and biological role in MM is unclear. The aim of the present study was to determine the expression pattern, biological role, and mechanism of miR-335 in MM. In this study, we found that miR-335 expression was decreased in MM. The promoter of miR-335 was also hypermethylated in MM. It was found that over-expression of miR-335 or 5-azacytidine treatment suppressed migration of MM cells and down-regulated the expression of IGF-1R. MiR-335 thus acts as a metastatic suppressor by targeting IGF-1R in MM. Moreover, aberrant promoter hyper-methylation is critical for miR-335 silencing in MM. We also found that miR-335 assisted in predicting both the prognosis and progression of disease in MM patients. Observations might offer a new complementary diagnostic and therapeutic target in MM.
引用
收藏
页码：3188 / 3198
页数：11
相关论文
共 50 条
  • [1] Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
    Kuhn, Deborah J.
    Berkova, Zuzana
    Jones, Richard J.
    Woessner, Richard
    Bjorklund, Chad C.
    Ma, Wencai
    Davis, R. Eric
    Lin, Pei
    Wang, Hua
    Madden, Timothy L.
    Wei, Caimiao
    Baladandayuthapani, Veerabhadran
    Wang, Michael
    Thomas, Sheeba K.
    Shah, Jatin J.
    Weber, Donna M.
    Orlowski, Robert Z.
    BLOOD, 2012, 120 (16) : 3260 - 3270
  • [2] MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor
    Hou, Ren
    Wang, Daixian
    Lu, Jian
    ONCOLOGY LETTERS, 2017, 13 (06) : 5009 - 5015
  • [3] Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
    Yin, Shucheng
    Girnita, Ada
    Stromberg, Thomas
    Khan, Zahidul
    Andersson, Sandra
    Zheng, Huiyuan
    Ericsson, Christer
    Axelson, Magnus
    Nister, Monica
    Larsson, Olle
    Ekstrom, Tomas J.
    Girnita, Leonard
    NEURO-ONCOLOGY, 2010, 12 (01) : 19 - 27
  • [4] Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention
    Zhang, Qi
    Pan, Jing
    Lubet, Ronald A.
    Wang, Yian
    You, Ming
    MOLECULAR CARCINOGENESIS, 2015, 54 : E129 - E137
  • [5] Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor
    Sherajee, Shamshad J.
    Fujita, Yoshiko
    Rafiq, Kazi
    Nakano, Daisuke
    Mori, Hirohito
    Masaki, Tsutomu
    Hara, Taiga
    Kohno, Masakazu
    Nishiyama, Akira
    Hitomi, Hirofumi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 257 - U193
  • [6] Glycan Modulation of Insulin-like Growth Factor-1 Receptor
    Boothello, Rio S.
    Sankaranarayanan, Nehru Viji
    Sistla, Jyothi C.
    Nagarajan, Balaji
    Sharon, Chetna
    Chittum, John E.
    Niyaz, Rabiya Y.
    Roy, Swarnali
    Nandi, Aditi
    O'Hara, Connor P.
    Gangji, Rahaman Navaz
    Afosah, Daniel K.
    Ongolu, Ravikumar
    Patel, Bhaumik B.
    Desai, Umesh R.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (49)
  • [7] Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
    Kasprzak, Aldona
    Adamek, Agnieszka
    Przybyszewska, Wieslawa
    Pyda, Przemyslaw
    Szmeja, Jacek
    Seraszek-Jaros, Agnieszka
    Lanzafame, Agata
    Surdacka, Anna
    Mozer-Lisewska, Iwona
    Koczorowska, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3867 - 3875
  • [8] Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
    Subramani, Ramadevi
    Lopez-Valdez, Rebecca
    Arumugam, Arunkumar
    Nandy, Sushmita
    Boopalan, Thiyagarajan
    Lakshmanaswamy, Rajkumar
    PLOS ONE, 2014, 9 (05):
  • [9] Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
    Desbois-Mouthon, Christele
    Baron, Aurore
    Blivet-Van Eggelpoel, Marie-Jose
    Fartoux, Laetitia
    Venot, Corinne
    Bladt, Friedhelm
    Housset, Chantal
    Rosmorduc, Olivier
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5445 - 5456
  • [10] Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma
    Pappa, C. A.
    Tsirakis, G.
    Psarakis, F. E.
    Kolovou, A.
    Tsigaridaki, M.
    Stafylaki, D.
    Sfiridaki, K.
    Alexandrakis, M. G.
    MEDICAL ONCOLOGY, 2013, 30 (01)
12345